Eric Ankerud

Executive Vice President, Clinical, Regulatory and Quality, Ocular Therapeutix

Eric Ankerud has more than 25 years of product approval experience covering a wide range of pharmaceuticals, medical devices, and biologics. He joined Ocular Therapeutix in 2007, also serving as Executive Vice President, Clinical, Regulatory and Quality at a sister company Augmenix from 2008 until April 2014. Previously, Mr. Ankerud was the Vice President, Clinical, Regulatory and Quality of Confluent Surgical, Inc., and prior to this, held senior executive positions at Boston Scientific Corporation, Summit Technology, Inc., and Bausch + Lomb. He has also held senior management roles within C.R. Bard and its Surgical Products Group. Mr. Ankerud received a B.A. degree with highest honors in economics from St. Lawrence University and a J.D. degree from the Faculty of Law and Jurisprudence, State University of New York at Buffalo.

All Sessions by Eric Ankerud

  • May 1, 2024

    Wednesday

  • 10:30 AM  - 11:15 AM
    Stryker, a global leader in medical technologies, has been at the forefront of additive manufacturing innovation for more than a decade. Stryker’s mission – together with our customers, we are driven to make healthcare better – provides a north star for culture and living our purpose. Stryker’s Global AMagine® Institute has led the industry in developing cutting-edge additive manufacturing technology, resulting in game-changing products to make healthcare better. This talk will delve into how Stryker uses additive manufacturing to develop, industrialize and innovate new healthcare solutions across joint replacement, spine, and other medical applications.
    Manufacturing & Materials
    Where
    162A

  • 10:30 AM  - 11:15 AM
    Baxter’s Chief of Digital Platforms & Innovation Donny Patel will lead a conversation around connected care – the current landscape, the opportunities and challenges the industry faces in advancing connected care, and what the future looks like for device connectivity in the hospital setting and beyond.
    New Tools & Tech
    Where
    162B

  • 2:45 PM  - 3:30 PM
    Learn how to incorporate biocompatibility testing into the design process of medical devices and drug delivery systems, aligning with ISO 10993 and other relevant standards. This presentation by PSN Labs provides guidance on material selection, manufacturing techniques, and device design to ensure biocompatibility from early development stages. Discover how to address evolving regulations and scientific advancements to prevent late-stage biocompatibility issues in the final product. Gain insights into strategies for identifying appropriate biological evaluation plans based on device classification. By integrating biocompatibility considerations into design, manufacturers enhance patient safety, streamline regulatory compliance, and minimize risks of delays and recalls. Join us to explore key aspects of biocompatible device design and learn how to proactively address challenges for successful product development.

    Sponsored By
    New Product Development
    Where
    161




Share

Eric Ankerud